Serum PCSK6 and corin levels are not associated with cardiovascular outcomes in patients undergoing coronary angiography

English version

Autoři: Shang-Feng Yang ^aff001; Ruey-Hsing Chou ^aff002; Shing-Jong Lin ^aff002; Szu-Yuan Li ^aff002; Po-Hsun Huang ^aff002
Působiště autorů: Division of Nephrology, Department of Medicine, Cheng Hsin General Hospital, Taipei, Taiwan ^aff001; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan ^aff002; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan ^aff003; Department of Critical Care Medicine, Taipei Veterans General Hospital, Taipei, Taiwan ^aff004; Healthcare and Management Center, Taipei Veterans General Hospital, Taipei, Taiwan ^aff005; Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan ^aff006; Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan ^aff007; Cardiovascular Research Center, Taipei Veterans General Hospital, Taipei, Taiwan ^aff008
Vyšlo v časopise: PLoS ONE 14(12)
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pone.0226129

Souhrn

Introduction

Proprotein convertase subtilisin/kexin-6 (PCSK6) is a secretory protein that activates corin in the heart. Higher circulating levels of corin are associated with improved cardiovascular outcomes in patients with acute myocardial infarction. This study aimed to determine the role of serum PCSK6 and corin levels in predicting cardiovascular outcomes in patients with suspected coronary artery disease (CAD).

Materials and methods

In total, 565 patients who had undergone coronary angiography were enrolled. Serum PCSK6 and corin levels were determined before the administration of contrast media. In this study, coronary revascularization, acute myocardial infarction, acute stroke, and death were defined as cardiovascular outcomes. All patients were followed up for at least one year after coronary angiography or until the occurrence of death.

Results

During a median follow-up of 691 days, 67 patients (15.7%) developed composite cardiovascular outcomes after coronary angiography, including 51 incidents of coronary revascularization, 7 instances of acute myocardial infarction, 2 acute strokes, and 15 deaths. After adjustment for demographic characteristics and all significant variables in the univariate analysis, serum levels of neither PCSK6 nor corin were associated with increased risk for cardiovascular outcomes. This correlation remained insignificant in patients with underlying hypertension, diabetes mellitus, CAD, heart failure, or chronic kidney disease (CKD). However, in patients without CKD, higher serum PCSK6 levels were associated with increased risk for cardiovascular outcomes (hazard ratio 1.380; 95% confidence interval 1.023–1.862).

Conclusions

We found no association between cardiovascular outcomes and pre-procedural serum levels of PCSK6 or corin in patients undergoing coronary angiography. However, an increased risk was seen in non-CKD patients with higher PCSK6 levels. Further studies are needed to verify these results.

Klíčová slova:

Coronary heart disease – Angiography – Hypertension – Chronic kidney disease – Myocardial infarction – Heart failure – Coronary revascularization

Zdroje

1. Wu Q, Xu-Cai YO, Chen S, Wang W. Corin: new insights into the natriuretic peptide system. Kidney Int. 2009;75(2):142–6. doi: 10.1038/ki.2008.418 18716601

2. Dong N, Chen S, Wang W, Zhou Y, Wu Q. Corin in clinical laboratory diagnostics. Clin Chim Acta. 2012;413(3–4):378–83. doi: 10.1016/j.cca.2011.10.032 22093942

3. Knappe S, Wu F, Masikat MR, Morser J, Wu Q. Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin. J Biol Chem. 2003;278(52):52363–70. Epub 2003/10/16. doi: 10.1074/jbc.M309991200 14559895.

4. Gladysheva IP, Wang D, McNamee RA, Houng AK, Mohamad AA, Fan TM, et al. Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy. Hypertension. 2013;61(2):327–32. Epub 2012/12/13. doi: 10.1161/HYPERTENSIONAHA.112.193631 23232642

5. Tran KL, Lu X, Lei M, Feng Q, Wu Q. Upregulation of corin gene expression in hypertrophic cardiomyocytes and failing myocardium. Am J Physiol Heart Circ Physiol. 2004;287(4):H1625–31. Epub 2004/06/12. doi: 10.1152/ajpheart.00298.2004 15191894.

6. Rame JE, Drazner MH, Post W, Peshock R, Lima J, Cooper RS, et al. Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload. Hypertension. 2007;49(4):857–64. doi: 10.1161/01.HYP.0000258566.95867.9e 17296875.

7. Rame JE, Tam SW, McNamara D, Worcel M, Sabolinski ML, Wu AH, et al. Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy. Circ Heart Fail. 2009;2(6):541–8. doi: 10.1161/CIRCHEARTFAILURE.109.866822 19919978

8. Dries DL, Victor RG, Rame JE, Cooper RS, Wu X, Zhu X, et al. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation. 2005;112(16):2403–10. doi: 10.1161/CIRCULATIONAHA.105.568881 16216958.

9. Chen S, Cao P, Dong N, Peng J, Zhang C, Wang H, et al. PCSK6-mediated corin activation is essential for normal blood pressure. Nat Med. 2015;21(9):1048–53. doi: 10.1038/nm.3920 26259032

10. Volpe M, Rubattu S. Novel Insights Into the Mechanisms Regulating Pro-Atrial Natriuretic Peptide Cleavage in the Heart and Blood Pressure Regulation: Proprotein Convertase Subtilisin/Kexin 6 Is the Corin Activating Enzyme. Circ Res. 2016;118(2):196–8. doi: 10.1161/CIRCRESAHA.115.307875 26838312.

11. Seidah NG, Prat A. The biology and therapeutic targeting of the proprotein convertases. Nat Rev Drug Discov. 2012;11(5):367–83. Epub 2012/06/12. doi: 10.1038/nrd3699 22679642.

12. Li JP, Wang XB, Chen CZ, Xu X, Hong XM, Xu XP, et al. The association between paired basic amino acid cleaving enzyme 4 gene haplotype and diastolic blood pressure. Chin Med J (Engl). 2004;117(3):382–8. Epub 2004/03/27. 15043778.

13. Zhou Y, Wu Q. Corin in natriuretic peptide processing and hypertension. Curr Hypertens Rep. 2014;16(2):415. doi: 10.1007/s11906-013-0415-7 24407448

14. Zhou X, Chen JC, Liu Y, Yang H, Du K, Kong Y, et al. Plasma Corin as a Predictor of Cardiovascular Events in Patients With Chronic Heart Failure. JACC Heart Fail. 2016;4(8):664–9. doi: 10.1016/j.jchf.2016.03.006 27179834.

15. Zhou X, Chen J, Zhang Q, Shao J, Du K, Xu X, et al. Prognostic Value of Plasma Soluble Corin in Patients With Acute Myocardial Infarction. J Am Coll Cardiol. 2016;67(17):2008–14. doi: 10.1016/j.jacc.2016.02.035 27126527.

16. Hu W, Chen S, Song Y, Zhu F, Shi J, Han X, et al. Serum Soluble Corin Deficiency Predicts Major Disability within 3 Months after Acute Stroke. PLoS One. 2016;11(9):e0163731. doi: 10.1371/journal.pone.0163731 27658255

17. Peleg A, Ghanim D, Vered S, Hasin Y. Serum corin is reduced and predicts adverse outcome in non-ST-elevation acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2013;2(2):159–65. doi: 10.1177/2048872613483588 24222826

18. Yang SF, Chou RH, Li SY, Huang SS, Huang PH. Serum Corin Level Is Associated With Subsequent Decline in Renal Function in Patients With Suspected Coronary Artery Disease. J Am Heart Assoc. 2018;7(10). Epub 2018/05/08. doi: 10.1161/JAHA.117.008157 29728370

19. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937–44. doi: 10.1681/ASN.2006040368 16988059.

20. Tsuji A, Sakurai K, Kiyokage E, Yamazaki T, Koide S, Toida K, et al. Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix. Biochim Biophys Acta. 2003;1645(1):95–104. Epub 2003/01/22. doi: 10.1016/s1570-9639(02)00532-0 12535616.

21. Blanchet MH, Le Good JA, Mesnard D, Oorschot V, Baflast S, Minchiotti G, et al. Cripto recruits Furin and PACE4 and controls Nodal trafficking during proteolytic maturation. EMBO J. 2008;27(19):2580–91. Epub 2008/09/06. doi: 10.1038/emboj.2008.174 18772886

22. Brandler WM, Paracchini S. The genetic relationship between handedness and neurodevelopmental disorders. Trends Mol Med. 2014;20(2):83–90. Epub 2013/11/28. doi: 10.1016/j.molmed.2013.10.008 24275328

23. Scamuffa N, Basak A, Lalou C, Wargnier A, Marcinkiewicz J, Siegfried G, et al. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7. Gut. 2008;57(11):1573–82. Epub 2008/07/31. doi: 10.1136/gut.2007.141812 18664504.

24. Pagani A, Vieillevoye M, Nai A, Rausa M, Ladli M, Lacombe C, et al. Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble form. Haematologica. 2015;100(4):458–65. Epub 2015/02/01. doi: 10.3324/haematol.2014.118521 25637053

25. Wang W, Liao X, Fukuda K, Knappe S, Wu F, Dries DL, et al. Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circ Res. 2008;103(5):502–8. doi: 10.1161/CIRCRESAHA.108.177352 18669922

26. Dong N, Fang C, Jiang Y, Zhou T, Liu M, Zhou J, et al. Corin mutation R539C from hypertensive patients impairs zymogen activation and generates an inactive alternative ectodomain fragment. J Biol Chem. 2013;288(11):7867–74. doi: 10.1074/jbc.M112.411512 23372161

27. Cui Y, Wang W, Dong N, Lou J, Srinivasan DK, Cheng W, et al. Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy. Nature. 2012;484(7393):246–50. Epub 2012/03/23. doi: 10.1038/nature10897 22437503

28. Barnet CS, Liu X, Body SC, Collard CD, Shernan SK, Muehlschlegel JD, et al. Plasma corin decreases after coronary artery bypass graft surgery and is associated with postoperative heart failure: a pilot study. J Cardiothorac Vasc Anesth. 2015;29(2):374–81. Epub 2015/02/05. doi: 10.1053/j.jvca.2014.11.001 25649697

29. Jiang J, Zhou Q, Sun M, Zuo F, Jiang J. Corin is highly expressed in atherosclerosis models. Biochem Biophys Res Commun. 2018;504(2):440–6. Epub 2018/09/10. doi: 10.1016/j.bbrc.2018.08.173 30195494.